Your browser doesn't support javascript.
loading
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
McCarthy, Eoghan M; Sutton, Emily; Nesbit, Stephanie; White, James; Parker, Ben; Jayne, David; Griffiths, Bridget; Isenberg, David A; Rahman, Anisur; Gordon, Caroline; D'Cruz, David P; Rhodes, Benjamin; Lanyon, Peter; Vital, Edward M; Yee, Chee-Seng; Edwards, Christopher J; Teh, Lee-Suan; Akil, Mohammed; McHugh, Neil J; Zoma, Asad; Bruce, Ian N.
Afiliação
  • McCarthy EM; The Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester.
  • Sutton E; Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester.
  • Nesbit S; Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester.
  • White J; Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester.
  • Parker B; The Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester.
  • Jayne D; Division of Musculoskeletal & Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester.
  • Griffiths B; Department of Medicine, Addenbooke's Hospital, Cambridge.
  • Isenberg DA; Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne.
  • Rahman A; Division of Rheumatology, University College London, Rayne Institute, London.
  • Gordon C; Division of Rheumatology, University College London, Rayne Institute, London.
  • D'Cruz DP; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham.
  • Rhodes B; Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham.
  • Lanyon P; Louise Coote Lupus Unit, Guys Hospital, London.
  • Vital EM; Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Old Queen Elizabeth Hospital, Birmingham.
  • Yee CS; Rheumatology Department, Nottingham University Hospitals NHS Trust, Nottingham.
  • Edwards CJ; Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds.
  • Teh LS; NIHR Leeds Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds.
  • Akil M; Department of Rheumatology, Doncaster and Bassetlaw Hospitals NHS Foundation Trust, Doncaster.
  • McHugh NJ; Musculoskeletal Research Unit, NIHR Wellcome Trust Clinical Research facility, The University of Southampton.
  • Zoma A; Department of Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton.
  • Bruce IN; Department of Rheumatology, Royal Blackburn Hospital, Blackburn.
Rheumatology (Oxford) ; 57(3): 470-479, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29216396
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Antirreumáticos / Rituximab / Lúpus Eritematoso Sistêmico Tipo de estudo: Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Antirreumáticos / Rituximab / Lúpus Eritematoso Sistêmico Tipo de estudo: Evaluation_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article